Sentences with phrase «identify human embryonic stem»

With the new SIF - seq technique, mouse embryonic stem cells can be used to identify human embryonic stem cell enhancers even when the human enhancers are not present in the mouse genome.

The ability of SIF - seq to use reporter assays in mouse embryonic stem cells to identify human embryonic stem cell enhancers that are not present in the mouse genome opens the door to intriguing research possibilities as Dickel explains.

Not exact matches

Researchers at the Babraham Institute and the Karolinska Institute report today in Cell Stem Cell that they have identified a set of proteins (molecular «flags») that are present on the surface of either naïve or primed human embryonic stem ceStem Cell that they have identified a set of proteins (molecular «flags») that are present on the surface of either naïve or primed human embryonic stem cestem cells.

In work published on 24 November in the journal Nature biotechnology, Anselme Perrier's team at I - Stem identified a recurrent anomaly in the genome of human embryonic stem cells left in culture for too lStem identified a recurrent anomaly in the genome of human embryonic stem cells left in culture for too lstem cells left in culture for too long.

Human embryonic stem cellsImage: Wikimedia commons, Nissim BenvenistyThe California Institute of Regenerative Medicine (CIRM) identified the underperforming projects by reviewing gr

For the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrostem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrophy.

Using pre-implantation genetic diagnosis derived human embryonic stem cell lines (hES) or human induced pluripotent stem cells carrying the causal mutation for neuro - muscular diseases, our objective is double: identify new physiopathogical mechanisms and develop new therapeutic strategies.

Even though different cell types were used as the initial starting materials, and they were made to produce different sets of proteins, both groups identified and isolated cells nearly identical to human embryonic stem cells, and did so in the same timeframe.

We identified an efficient OCT4 - targeting guide RNA using an inducible human embryonic stem cell - based system and microinjection of mouse zygotes.

Dr. John Gearhart, who led a research team that first identified and isolated human embryonic stem cells, is named director of the institute.